Efficacy and Safety of Low-Dose Apatinib Combined with Chemotherapy as Second-Line Treatment for Advanced Gastric Cancer: A Meta-Analysis.
用户EO9nReo4Hj6s
10小时前
13
10
待确认
帖子自动结束时间: 2025-05-02 11:19:10
1. 请及时下载文件确认是否正确, 系统将在 2025-05-04 14:56:27 删除文件
2. 如若文件有误请驳回应助文件, 求助状态即回到求助中
3. 如若文件正确请及时点击确认, 若超过时后系统自动默认为已完结
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI:
文献链接:
其他信息:
L Wang, J Li, H Chen
Chemotherapy (0009-3157), 2024
search.ebscohost.com
Introduction: At present, there are several studies on low-dose apatinib combined with chemotherapy as a second-line treatment of advanced gastric cancer (AGC), but the …